Free Trial

DocGo Inc. (NASDAQ:DCGO) Shares Sold by Millennium Management LLC

DocGo logo with Medical background

Millennium Management LLC reduced its stake in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 70.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 77,254 shares of the company's stock after selling 187,159 shares during the period. Millennium Management LLC owned 0.08% of DocGo worth $328,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in DCGO. Invesco Ltd. grew its holdings in DocGo by 1.3% in the 4th quarter. Invesco Ltd. now owns 177,953 shares of the company's stock valued at $755,000 after buying an additional 2,312 shares in the last quarter. Summit Investment Advisors Inc. boosted its position in shares of DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after acquiring an additional 2,968 shares during the last quarter. Rhumbline Advisers grew its holdings in shares of DocGo by 4.5% in the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company's stock valued at $605,000 after purchasing an additional 6,204 shares during the period. Victory Capital Management Inc. grew its holdings in shares of DocGo by 12.3% in the fourth quarter. Victory Capital Management Inc. now owns 57,649 shares of the company's stock valued at $244,000 after purchasing an additional 6,300 shares during the period. Finally, MetLife Investment Management LLC increased its position in DocGo by 12.1% during the fourth quarter. MetLife Investment Management LLC now owns 60,245 shares of the company's stock worth $255,000 after purchasing an additional 6,517 shares during the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Price Performance

Shares of DCGO stock traded down $0.04 on Thursday, hitting $1.50. The stock had a trading volume of 106,552 shares, compared to its average volume of 784,878. The company's 50 day moving average price is $1.89 and its 200-day moving average price is $3.31. DocGo Inc. has a 1 year low of $1.23 and a 1 year high of $5.68. The firm has a market capitalization of $152.46 million, a P/E ratio of 5.34, a P/E/G ratio of 14.16 and a beta of 0.94.

DocGo (NASDAQ:DCGO - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). DocGo had a return on equity of 8.90% and a net margin of 4.35%. The business had revenue of $96.03 million for the quarter, compared to analysts' expectations of $104.25 million. On average, equities analysts forecast that DocGo Inc. will post 0.25 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on DCGO shares. Canaccord Genuity Group reiterated a "hold" rating and issued a $1.45 target price (down from $5.00) on shares of DocGo in a report on Monday, May 12th. Stifel Nicolaus lowered their price objective on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Needham & Company LLC decreased their price target on DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. Deutsche Bank Aktiengesellschaft cut DocGo from a "buy" rating to a "hold" rating and lowered their price target for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $3.56.

View Our Latest Report on DCGO

About DocGo

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Stories

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines